FDA Provides New & Revised Product-Specific Guidances

FDA Provides New & Revised Product-Specific Guidances

The U.S. Food and Drug Administration (FDA) has issued 22 new and 14 revised product-specific guidances (PSGs) for generic drug development. The guidances provide further clarity to the FDA’s expectations in regards to clinical studies demonstrating...